Modern Diagnostics: A Pillar of Precision Medicine
At the McKAIZER Research & Application Institute, diagnostic testing is regarded as an indispensable foundation of precision medicine. The Institute focuses on researching and applying cutting-edge technologies such as molecular biology, genetic analysis, cellular technologies, and artificial intelligence to deliver fast, accurate, and highly reliable results.
Key Research Focus Areas Include:
Genetic testing for personalized medicine.
Cytology and immunology testing.
Biomarker analysis for cancer and chronic diseases.
Diagnostic solutions supporting prevention and early treatment.
Beyond research, McKAIZER emphasizes technology transfer and the development of practical testing models for clinical application, enhancing diagnostic and treatment effectiveness across Vietnam.
Optimizing Critical Elements in Diagnostic Technology
According to the Institute’s strategic vision, modern diagnostic technology is sustainable only when its critical elements are developed in tandem: accuracy, speed, safety, clinical applicability, and data integration. High sensitivity and specificity allow physicians to design personalized treatment plans based on each patient’s genetic profile and biological markers.
Point-of-Care Testing (POCT) Development
To meet the growing demand for rapid and convenient testing, McKAIZER is developing Point-of-Care Testing (POCT) devices, bridging the gap between laboratory analysis and clinical practice.
A notable example is the rapid NAD+ test kit, enabling users to measure NAD+ levels—a key factor related to aging, cellular energy, and overall health—quickly and accurately with a simple procedure.
The combination of POCT and the rapid NAD+ kit empowers individuals to actively manage their health, while promoting the advancement of precision and personalized medicine in Vietnam.
Integration of Artificial Intelligence and Big Data
McKAIZER leverages AI and Big Data across the diagnostic workflow: from assay design and sample management to result interpretation and disease trend prediction.
AI automatically identifies complex sample patterns.
Minimizes analytical errors.
Provides evidence-based diagnostic and treatment recommendations.
As a result, McKAIZER’s diagnostic technology goes beyond mere testing, becoming a comprehensive healthcare data platform that supports chronic disease management and preventive care for individuals.
Quality Standardization and Data Security
To ensure efficacy and user trust, McKAIZER strictly adheres to international quality management standards, including:
Equipment calibration.
Inter-laboratory quality control.
Absolute patient data confidentiality.
These measures establish a foundation where McKAIZER’s diagnostic technology is not only legally compliant and safe but also earns credibility and trust within Vietnam’s healthcare system.
